Use of Probiotic Bacteria in Prevention of Allergic Disease in Children 1999-2008
Phase 2
- Conditions
- Atopic DermatitisFood HypersensitivityAllergic Rhinitis, SeasonalAllergic ConjunctivitisAsthma
- Registration Number
- NCT00298337
- Lead Sponsor
- University of Helsinki
- Brief Summary
The aim of the study is to find out if allergic diseases can be prevented buy giving probiotic bacteria to pregnant mothers and their newborn infants
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- mother or father fo child with doctor diagnoses allergic disease
Exclusion Criteria
- prematurity, major malformations
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie probiotic prevention of atopic dermatitis in neonates?
How does probiotic intervention during pregnancy compare to allergen avoidance in reducing childhood asthma incidence?
Which gut microbiota biomarkers correlate with allergic disease prevention in NCT00298337 participants?
What adverse events were reported in probiotic trials for maternal and infant allergy prevention (1999-2008)?
Are prebiotic-probiotic combinations more effective than Lactobacillus rhamnosus alone for food hypersensitivity prevention?
Trial Locations
- Locations (1)
Helsinki University Central Hospital, Skin and Allergy Hospital
🇫🇮Helsinki, PO box 160, Finland
Helsinki University Central Hospital, Skin and Allergy Hospital🇫🇮Helsinki, PO box 160, Finland